Carl L. Gordon

Insider Reports History

Entity
Individual
Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Signature
/s/ Carl L. Gordon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl L. Gordon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Venetian-1 Acquisition Corp. Director Common Stock 2.68M $10.7M $4.00 Nov 1, 2024 Indirect
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 756K $7.56M $10.00 Jul 16, 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Common Stock 1.51M $5.52M $3.65 Jan 30, 2024 Indirect
Keros Therapeutics, Inc. Director Common Stock 120K $5.26M $44.01 Aug 13, 2024 Indirect
Adicet Bio, Inc. Director, 10%+ Owner Common Stock 647K $925K $1.43 Jun 5, 2024 Indirect
Adicet Bio, Inc. Director, 10%+ Owner Common Stock 11.8K $16.9K $1.43 Jun 5, 2024 Direct
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 0 $0 $2.59 Apr 3, 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 0 $0 $3.05 Feb 14, 2024 Indirect
Theseus Pharmaceuticals, Inc. Director, 10%+ Owner Restricted Stock Units 0 $0 $3.05 Feb 14, 2024 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 3.16M Sep 16, 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Common Stock 654K Sep 16, 2024 By OrbiMed Genesis Master Fund, L.P.
Compass Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 40K Feb 9, 2024 Direct
Adicet Bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 26.4K Aug 21, 2024 Direct
Gemini Therapeutics, Inc. /DE Director, 10%+ Owner Stock Option (Right to Buy) 17.2K Oct 4, 2021 Direct
Oric Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (right to buy) 16.6K Jun 16, 2021 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 16K Sep 12, 2024 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10K May 30, 2024 Direct
Terns Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 4.68K Jul 1, 2024 Direct
ArriVent Biopharma, Inc. Director, 10%+ Owner Series A Preferred Stock 0 Jan 30, 2024 Indirect
ArriVent Biopharma, Inc. Director, 10%+ Owner Series B Preferred Stock 0 Jan 30, 2024 Indirect
Kinnate Biopharma Inc. Director, 10%+ Owner Stock Option (right to buy) 0 Apr 3, 2024 Direct
MBX Biosciences, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Private Investments VII, LP
MBX Biosciences, Inc. Director, 10%+ Owner Series C Convertible Preferred Stock 0 Sep 16, 2024 By OrbiMed Genesis Master Fund, L.P.
Venetian-1 Acquisition Corp. Director Simple Agreement for Future Equity 0 Nov 1, 2024 Indirect

Insider Reports Filed by Carl L. Gordon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NONE Lomond Therapeutics Holdings, Inc. Nov 1, 2024 13 $10M 4 Nov 5, 2024 Director
NONE Lomond Therapeutics Holdings, Inc. Nov 1, 2024 0 $0 3 Nov 5, 2024 Director
MBX MBX Biosciences, Inc. Sep 16, 2024 7 $12M 4 Sep 17, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 1 $0 4 Sep 13, 2024 Director, 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director, 10%+ Owner
ACET Adicet Bio, Inc. Aug 21, 2024 8 $0 4 Aug 23, 2024 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Aug 13, 2024 2 -$11M 4 Aug 15, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jul 15, 2024 6 -$562K 4 Jul 17, 2024 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Jul 1, 2024 1 $0 4 Jul 2, 2024 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 14, 2024 Director, 10%+ Owner
ACET Adicet Bio, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
KNTE Kinnate Biopharma Inc. Apr 3, 2024 8 $0 4 Apr 5, 2024 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Feb 14, 2024 3 $0 4 Feb 14, 2024 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Feb 9, 2024 1 $0 4 Feb 14, 2024 Director, 10%+ Owner
AVBP ArriVent Biopharma, Inc. Jan 30, 2024 10 $8M 4 Jan 31, 2024 Director, 10%+ Owner
ACET Adicet Bio, Inc. Jan 25, 2024 3 $7.5M 4 Jan 26, 2024 Director, 10%+ Owner
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 Director, 10%+ Owner
ACET Adicet Bio, Inc. Aug 14, 2023 8 $0 4 Aug 16, 2023 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jul 17, 2023 2 $1.46M 4 Jul 19, 2023 Director, 10%+ Owner
ACET Adicet Bio, Inc. Jun 27, 2023 4 $1.83M 4 Jun 29, 2023 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jun 13, 2023 2 $0 4 Jun 13, 2023 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
ACET Adicet Bio, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
KNTE Kinnate Biopharma Inc. May 4, 2023 5 $4.09M 4 May 8, 2023 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Apr 28, 2023 9 $3.67M 4 May 2, 2023 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Feb 17, 2023 2 $0 4 Feb 22, 2023 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Feb 8, 2023 1 $0 4 Feb 9, 2023 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Dec 23, 2022 1 $1M 4 Dec 28, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Nov 8, 2022 1 $1.29M 4 Nov 10, 2022 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Nov 7, 2022 1 $1M 4 Nov 9, 2022 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Aug 16, 2022 6 $8.93M 4 Aug 18, 2022 Director, 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
THRX Theseus Pharmaceuticals, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director, 10%+ Owner
ACET Adicet Bio, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
KROS Keros Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
CMPX Compass Therapeutics, Inc. May 11, 2022 3 $420K 4 May 13, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. May 6, 2022 3 $197K 4 May 10, 2022 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Feb 18, 2022 1 $0 4 Feb 23, 2022 Director, 10%+ Owner
KNTE Kinnate Biopharma Inc. Feb 11, 2022 4 $1.99M 4 Feb 15, 2022 Director
THRX Theseus Pharmaceuticals, Inc. Jan 19, 2022 3 $1.58M 4 Jan 21, 2022 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Jan 11, 2022 4 $443K 4 Jan 13, 2022 Director, 10%+ Owner
ACET Adicet Bio, Inc. Dec 10, 2021 1 $3M 4 Dec 14, 2021 Director, 10%+ Owner
CMPX Compass Therapeutics, Inc. Nov 4, 2021 2 $18.8M 4 Nov 8, 2021 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 12, 2021 7 $10M 4 Oct 14, 2021 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 1 $0 4 Oct 8, 2021 Director, 10%+ Owner
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 Director, 10%+ Owner
IRON Gemini Therapeutics, Inc. /DE Oct 4, 2021 1 $0 4 Oct 6, 2021 Director, 10%+ Owner
ORIC Oric Pharmaceuticals, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director